Spero Therapeutics
SPRO
#9015
Rank
A$0.10 B
Marketcap
$2.00
Share price
0.76%
Change (1 day)
14.69%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of June 2024 : A$96.31 Million

According to Spero Therapeutics's latest financial reports the company has A$96.31 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.11 B-30.12%
2022-12-31A$0.16 B-20.6%
2021-12-31A$0.20 B22.36%
2020-12-31A$0.16 B40.84%
2019-12-31A$0.11 B-28.49%
2018-12-31A$0.16 B46.57%
2017-12-31A$0.11 B681.32%
2016-12-31A$14.3 M83.18%
2015-12-31A$7.81 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$55.45 M-42.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.77 B 21,468.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.70 B 2,709.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada